logo

Health News

Share SHARE
E-Cigarette-110916-lg.jpg

A new study shows that teens who "vape" e-cigarettes are more likely to move on to regular cigarettes. The survey was conducted over ten Los Angeles county schools. The study was published November 8 in the Journal of American Medical Association. Leading researcher Adam Leventhal cited that, "teens who vape frequently are more than twice as likely to start smoking on about a weekly basis."
More
A new controversial "three-parent baby" treatment may be available on the United Kingdoms National Health Service plan by next spring. The Daily Mail reports that "An independent panel of experts has cleared away remaining safety hurdles to recommend "cautious adoption" of mitochondrial replacement therapy (MRT) for devastating inherited diseases."
More
CVS-Vending-Machines-091217.jpg CVS Pharmacy will be launching health and wellness vending machines across the country to offer healthy snacks, personal care items as well as over-the-counter products to the customers on the go. The automated machines will be placed in airports, hotels, transportation hubs etc. and can be accessed using credit and debit cards. Aug2017-072717.jpg We are well into the second half of 2017. Now, let's take a look at the biotech stocks awaiting word from the FDA in August. untreatable-gonorrhea-071017.jpg There is a growing concern among the medical experts on the spread of antibiotic resistant and untreatable gonorrhea. More
tomato-112116.jpg Women who engage in yo-yo dieting may face a greater risk of heart disease, such as coronary heart disease and sudden cardiac death, according to a new study. The study, presented at the American Heart Association's Scientific Sessions 2016, featured 158,063 postmenopausal women split into four categories: stable weight, steady gain, maintained weight loss, and weight cycling. President Obama has proposed a new rule that prevents the defunding of Planned Parenthood in some states for political reasons. The proposition would prevent states from withholding Title X federal family planning money from constituents for any reasons other than their provider's "ability to deliver services to program beneficiaries in an effective manner." Vacutainer-blood-bottles-102616.jpg A new Canadian study finds that when it comes to blood transfusions, fresher blood is not any better than older blood. Nancy Heddle is a professor emeritus of medicine at McMaster University, in Hamilton, Ontario. Heddle cites, "Our study provides strong evidence that transfusion of fresh blood does not improve patient outcomes, and this should reassure clinicians that fresher is not better." More

AstraZeneca Reports Positive Lung Cancer Drug Data From Phase III FLAURA Trial



Drug maker AstraZeneca (AZN) announced the full results of Phase III FLAURA trial, which support TAGRISSO's clear potential as a new standard of care (SoC) in the 1st-line treatment of adult patients with locally-advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung...
More
Elililly-090717.jpg

Lilly Plans To Cut About 3,500 Jobs Globally



Eli Lilly and Co. (LLY) said Thursday that it plans to cut about 3,500 positions globally, as part of a streamlining plan. It expects to incur charges of about $1.2 billion pre-tax or $0.80 per share after-tax. It expects annualized savings of about $500 million that will begin to be realized in 2018.
More
Slide0-Alzheimers-081717.jpg

Race For A New Alzheimer's Drug



The development of Alzheimer's drugs has been marred by a high failure rate. A U.S. study, which analyzed how the Alzheimer's clinical trials fared during the period of 2002 to 2012, revealed a failure rate of 99.6% compared to a failure rate of 81% for cancer drugs.
More




Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
12/03/17MYLMYL-1401O (BLA)FDA decision on MYL-1401O as a proposed biosimilar to Roche's Herceptin
11/29/17KITEAxicabtagene ciloleucel (KTE-C19) (BLA)FDA decision on KTE-C19 for Non-Hodgkin Lymphoma
11/16/17RARERecombinant human beta-glucuronidase (BLA)FDA decision on rhGUS for the treatment of Mucopolysaccharidosis VII
11/10/17DVAXHEPLISAV-B (NDA resubmission)FDA decision on HEPLISAV-B for treatment of hepatitis B
11/09/17BMYSprycel (sNDA)FDA decision on Sprycel to treat children with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia
10/30/17EGRXPemetrexed Injection (NDA)FDA decision on Pemetrexed for the treatment of Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer, and Mesothelioma
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data